In order to value the epimutation of MGMT and BRCA1 in WBC from cancer-free women and newborns, we investigated the prevalence of the methylated BRCA1 and MGMT promoters in breast and ovarian cancer patients. The gene discussed is MGMT; the disease is cancer.